Captor Therapeutics Company

CAPTOR THERAPEUTICS SA is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technologyallows degradation of virtually any intracellular protein including the so-called "undruggable proteome".
Industry: PharmTech
Headquarters: Basel

Visit Website
Register and Claim Ownership